Gene Review:
MMP16 - matrix metallopeptidase 16 (membrane...
Homo sapiens
Synonyms:
C8orf57, DKFZp761D112, MMP-16, MMP-X2, MMPX2, ...
- Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen. Iida, J., Pei, D., Kang, T., Simpson, M.A., Herlyn, M., Furcht, L.T., McCarthy, J.B. J. Biol. Chem. (2001)
- Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas. Kitagawa, Y., Kunimi, K., Uchibayashi, T., Sato, H., Namiki, M. J. Urol. (1999)
- Membrane type-matrix metalloproteinases in idiopathic pulmonary fibrosis. García-Alvarez, J., Ramirez, R., Sampieri, C.L., Nuttall, R.K., Edwards, D.R., Selman, M., Pardo, A. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders. (2006)
- Expression of mRNA for membrane-type 1, 2, and 3 matrix metalloproteinases in human laryngeal cancer. Sun, Y.N., Li, Y. Chin. Med. Sci. J. (2004)
- beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Lowy, A.M., Clements, W.M., Bishop, J., Kong, L., Bonney, T., Sisco, K., Aronow, B., Fenoglio-Preiser, C., Groden, J. Cancer Res. (2006)
- Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Nakada, M., Yamada, A., Takino, T., Miyamori, H., Takahashi, T., Yamashita, J., Sato, H. Cancer Res. (2001)
- Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M., Okada, Y. Cancer Res. (1997)
- Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 8, respectively. Mattei, M.G., Roeckel, N., Olsen, B.R., Apte, S.S. Genomics (1997)
- Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features. Lang, R., Braun, M., Sounni, N.E., Noel, A., Frankenne, F., Foidart, J.M., Bode, W., Maskos, K. J. Mol. Biol. (2004)
- Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury. Shofuda, K., Nagashima, Y., Kawahara, K., Yasumitsu, H., Miki, K., Miyazaki, K. Lab. Invest. (1998)
- Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. Shimada, T., Nakamura, H., Ohuchi, E., Fujii, Y., Murakami, Y., Sato, H., Seiki, M., Okada, Y. Eur. J. Biochem. (1999)
- Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Pap, T., Shigeyama, Y., Kuchen, S., Fernihough, J.K., Simmen, B., Gay, R.E., Billingham, M., Gay, S. Arthritis Rheum. (2000)
- Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP. Plaisier, M., Kapiteijn, K., Koolwijk, P., Fijten, C., Hanemaaijer, R., Grimbergen, J.M., Mulder-Stapel, A., Quax, P.H., Helmerhorst, F.M., van Hinsbergh, V.W. J. Clin. Endocrinol. Metab. (2004)
- Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. Shofuda, K., Moriyama, K., Nishihashi, A., Higashi, S., Mizushima, H., Yasumitsu, H., Miki, K., Sato, H., Seiki, M., Miyazaki, K. J. Biochem. (1998)
- mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue. Jung, M., Römer, A., Keyszer, G., Lein, M., Kristiansen, G., Schnorr, D., Loening, S.A., Jung, K. Prostate (2003)
- Effect of Losartan on the mRNA Expressions of MT3-MMP and TIMP-2 in Diabetic Kidneys. Ding, H.L., Xu, M.T., Guo, Y., Chen, L., Zhang, S.L., Li, F., Fu, Z.Z. The review of diabetic studies : RDS (2005)
- Cleavage of Amyloid-{beta} Precursor Protein (APP) by Membrane-Type Matrix Metalloproteinases. Ahmad, M., Takino, T., Miyamori, H., Yoshizaki, T., Furukawa, M., Sato, H. J. Biochem. (2006)
- Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. Endo, K., Takino, T., Miyamori, H., Kinsen, H., Yoshizaki, T., Furukawa, M., Sato, H. J. Biol. Chem. (2003)
- A cryptic deletion of 2q35 including part of the PAX3 gene detected by breakpoint mapping in a child with autism and a de novo 2;8 translocation. Borg, I., Squire, M., Menzel, C., Stout, K., Morgan, D., Willatt, L., O'Brien, P.C., Ferguson-Smith, M.A., Ropers, H.H., Tommerup, N., Kalscheuer, V.M., Sargan, D.R. J. Med. Genet. (2002)
- Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues. Yoshiyama, Y., Sato, H., Seiki, M., Shinagawa, A., Takahashi, M., Yamada, T. Acta Neuropathol. (1998)
- Assignment of the human genes for membrane-type-1, -2, and -3 matrix metalloproteinases (MMP14, MMP15, and MMP16) to 14q12.2, 16q12.2-q21, and 8q21, respectively, by in situ hybridization. Sato, H., Tanaka, M., Takino, T., Inoue, M., Seiki, M. Genomics (1997)
- Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Uzui, H., Harpf, A., Liu, M., Doherty, T.M., Shukla, A., Chai, N.N., Tripathi, P.V., Jovinge, S., Wilkin, D.J., Asotra, K., Shah, P.K., Rajavashisth, T.B. Circulation (2002)